Last updated: 10 February 2021 at 5:34pm EST

Ventures Fund Iv General Pa... Net Worth




The estimated Net Worth of Ventures Fund Iv General Pa... is at least $74 dollars as of 8 February 2021. Ventures Pa owns over 215,000 units of Kaleido Biosciences Inc stock worth over $74 and over the last 4 years Ventures sold KLDO stock worth over $0.

Ventures Pa KLDO stock SEC Form 4 insiders trading

Ventures has made over 1 trades of the Kaleido Biosciences Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently Ventures bought 215,000 units of KLDO stock worth $2,472,500 on 8 February 2021.

The largest trade Ventures's ever made was buying 215,000 units of Kaleido Biosciences Inc stock on 8 February 2021 worth over $2,472,500. On average, Ventures trades about 215,000 units every 0 days since 2021. As of 8 February 2021 Ventures still owns at least 738,333 units of Kaleido Biosciences Inc stock.

You can see the complete history of Ventures Pa stock trades at the bottom of the page.



Insiders trading at Kaleido Biosciences Inc

Over the last 6 years, insiders at Kaleido Biosciences Inc have traded over $0 worth of Kaleido Biosciences Inc stock and bought 3,273,186 units worth $32,952,342 . The most active insiders traders include Ventures Fund Iv General Pa..., Joshua T Brumm, and Ventures Fund V General Par.... On average, Kaleido Biosciences Inc executives and independent directors trade stock every 119 days with the average trade being worth of $55. The most recent stock trade was executed by Daniel L Menichella on 8 February 2021, trading 20,000 units of KLDO stock currently worth $230,000.



What does Kaleido Biosciences Inc do?

the next breakthrough microbiome company from flagship venturelabs – the innovation foundry of flagship ventures – is coming.



Complete history of Ventures Pa stock trades at Kaleido Biosciences Inc

Insider
Trans.
Transaction
Total value
Ventures Fund Iv General Pa...
Buy $2,472,500
8 Feb 2021


Kaleido Biosciences Inc executives and stock owners

Kaleido Biosciences Inc executives and other stock owners filed with the SEC include: